We’re here to improve people’s lives by harnessing the power of AI in autoimmune diseases

Predicta Med’s Mission

Connecting the dots starts here

We are passionate about connecting dots and treating autoimmune diseases.
Recognition and treatment of these diseases represent one of the major unmet needs of today’s medical world.

We love empowering clinicians to provide earlier recognition and diagnosis, and offering better treatment to reduce disease progression by combining experts’ medical knowledge with cutting edge learning techniques.

We aim to improve the lives of millions of patients around the world by shortening the diagnostic journey and enabling early and effective treatment.

Our Story

How it all began

Predicta Med was founded in 2020 by Shlomit Steinberg-Koch, CEO, and Benny Getz, CTO.

Previously, Shlomit worked for Mazor Robotics where she led the development of Mazor’s flagship product in the field of software analytics, from ideation to delivery. She took part in establishing the innovation department of Mazor together with the company’s founders.

Benny, who has more than 25 years of experience in leading AI and development teams, worked for leading companies such as Intel, Samsung, and until recently, was the CTO of Kayhut.

Shlomit and Benny have recognized the huge challenge in the diagnostic process of autoimmune diseases, a process that today, on average, can take at least four different doctors and more than four years to make a definite diagnosis. These patients are enduring a frustrating journey through the medical system, in addition to incurring huge costs to the healthcare system.

Predicta Med is dedicated to connecting the dots of undiagnosed diseases, to empower primary care physicians, and most importantly, to improve the lives of patients.

Our Commitment

Closing the health equity gap

Company commitment to Diversity, Equity and inclusion (DEI) 
Predicta Med is committed to overcoming bias in underrepresented groups such as women, racial/ethnic minority groups, LGBTQIA and disabled persons. Predicta Med has increased the representation of women and racial/ethnic minority groups across the core company team, the medical advisory board and the strategic advisory board members.
We promote equal opportunity in hiring processes, create diverse interview panels and promote a culture of diversity, inclusion and acceptance as well as being mindful of determining flexible working policies

 

Technology commitment to Diversity, Equity and inclusion (DEI) 
The PredictAITM Machine Learning tool is able to democratize early diagnosis of autoimmune diseases without prejudicing the accuracy of the risk predictions when considering demographic location, socio economic status, sex and gender.
However, once the at-risk patient pool is identified, then the PredictAITM is able to analyse underrepresented groups, demographic differences, race/ethnicity and socio-economic status to see if isolated risk factors are more prevalent in specific subpopulations. This may allow for a more accurate, personalised and inclusive approach to early diagnosis.

The Team

Shlomit Steinberg-Koch

Co-Founder, CEO

Her first startup was established in 2012 in the field of Melanoma detection, based on an algorithm she developed.

 

In the past six years she has been working for Mazor Robotics in multiple roles including R&D projects management, Product and Project management roles and was the first employee of the innovation department.
She led several products in the field of neurosurgery and predictive analytics from concept to launch.

 

Shlomit holds a B.Sc. In biomedical engineering, and an MBA in technology management, innovation and entrepreneurship.

Benny Getz

Co-Founder, CTO

BSc Physics, Mathematics, MSc Electrical Engineering, MBA

 

A seasoned C-level executive with deep technological background . Responsible for leading the data science and machine learning research, technical innovation, and product development. Benny brings 25 years of research and development experience in the fields of signal processing, data science, and deep learning/AI as well as system engineering and design experience in both international corporates (Intel, Samsung, Elbit) and successful startups (Kagoor Networks, Siliquent Technologies, Kayhut).

Dan Underberger, MD

CMO

A board certified anesthesiologist and seasoned senior physician executive with 20+ years of clinical leadership, startup and healthcare informatics experience.

Prior to working with Predicta Med, Dr. Underberger served as Senior Medical Director at Medial EarlySign and has also served as the chief medical officer and clinical solution executive for both McKesson and Change Healthcare’s Software & Analytics Divisions.

He also founded and successfully exited two medical software companies.

Dr. Underberger received his MD at George Washington University School of Medicine, completed his anesthesia residency at the University of Arizona and was in private practice in St. Louis before deciding to trade his anesthesia machine for a PC.

Michael Dreyfuss, MD, PhD

Medical Director

Michael obtained his MD and PhD in neuroscience from Weill Cornell Medical College. During his doctoral work, Michael performed and published original research using functional MRI to examine the neural correlates of self-control in the brain. Following his MD-PhD, he joined K Health as a medical domain expert where he interfaced between medical domain knowledge and data science. At K, Michael developed a tool for medical quality assessment, planned the centralization of patient medical information and curated medical ontologies. Michael also holds a degree in linguistics obtained on a Fulbright research scholarship at the University of Toulouse.

Alon Shmueli

Engineering Manager

For more than 10 years, Alon has led the technology vision, strategy, design and architecture as engineering manager in a wide variety of industries.
He has led teams and been a technology leader at prominent brands such as Samsung and Intel along with wide range of Startup companies which the most know is Fiverr.com
Alon’s experience and knowledge supported by Computer Science bachelor degree and many professional trainings enables him leveraging technology to align with business strategy whilst ensuring maximum efficiency and quality.
Before joining Predicta Med, Alon was the VP R&D of Farm Dog, an Agriculture pest and disease management system which acquired lately, and moving forward to an additional company that really cares about people’s life inspired and excited him a lot.

Or Ramni

Senior Data Scientist

During her studies Or worked for two years at the Human Cognitive Neuroscience lab as a research assistant.

Later on she worked for three years at Orcam
as an algorithm developer in the Speech and Languages team, mainly working on deep learning projects.

She holds a B.Sc. in Computer science and Cognitive science at the Hebrew University
of Jerusalem.

Yonatan Jenudi, MD

Data Scientist

After he graduated from the Faculty of Medicine as a Doctor of Medicine, Yonatan continued his studies at the Faculty of Engineering to study programming and Data Science.

Yonatan has experience in coding algorithms in Deep Learning, Natural Language Processing, and Image Processing to solve world health issues.

He is passionate about combining his medical domain expertise with machine learning.

He holds an M.D and B.Sc in Data Science, both from Tel Aviv University.

 

Advisors

Prof. (Emer.) Yehuda Shoenfeld, MD, FRCP, MaACR

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center

Prof. Yehuda Shoenfeld, the founder of the Zabludowicz Center for Autoimmune Diseases at the Sheba Medical Center, is a truly unique person: he is a world leader in the research and treatment of autoimmune diseases, with more than 2,150 publications in leading scientific journals and a citation index exceeding 2600.

 

Prof. Shoenfeld is one of Israel’s top physicians and scientists, dedicating his life to two fields: autoimmunity and public health. He has already been awarded 24 prizes for his contributions to these fields, including the Eular 2005 award and the Ometz 2016 prize.

Stanley B. Cohen, MD

Physician at Rheumatology Associates of North Texas, PA

Dr. Cohen received his Doctor of Medicine with honors, from the University of Alabama School of Medicine in Birmingham. He completed an internship and residency in Internal Medicine, and a fellowship in Rheumatology at UT Southwestern/St. Paul University Hospital. His research group has participated in the development of nearly all the biologic therapies and targeted synthetic Dmards developed for inflammatory arthritis  in the last 23 years.

He has been involved in training of medical students, residents and rheumatology fellows. He is a past president of the American College of Rheumatology Research Foundation and the American College of Rheumatology  and was honored in 2016 with the designation of Master by the American College of Rheumatology. In 2021 he was awarded the ACR Presidential Gold Medal in recognition of outstanding achievements in rheumatology over an entire career.

Prof. Shomron Ben Horin, MD

Chief of the Gastroenterology Department at Sheba Medical Center

Professor Ben-Horin received his medical and Gastroenterology training in Israel and was a Post-Doc scientist in immunology at Columbia University Presbyterian Hospital in New-York, USA. Prof. Ben-Horin specializes in inflammatory bowel diseases (IBD). He is the Chief of the Gastroenterology Department at Sheba Medical Center, Israel, a Full Professor of Medicine at the Tel-Aviv University, and an Adjunct Professor of Medicine at the Sun Yat-Sen University Hospital, Guangzhou, China, where he worked as a visiting professor for one year in 2015-2016. He has served as a member of the Scientific Committee of the European Crohn’s & Colitis Organization (ECCO) and is presently the Chair of the Israeli IBD Society.

Prof. Ben-Horin has published over 200 peer-reviewed scientific papers and is a member of the Editorial Board of the journals Gut, APT and JCC. Prof. Ben-Horin is also the Director of IBD-passport: A web-based global non-for-profit support program for traveling IBD patients.

Sunanda V. Kane, MD, MSPH

Professor of Medicine at the Mayo Clinic

Dr. Kane is a Professor of Medicine at the Mayo Clinic in Rochester Minnesota. She has a busy clinical practice that reflects her expertise in inflammatory bowel disease (IBD), which is also the focus of her research work encompassing new therapies, gender-specific issues, and medication adherence. Amongst many leadership positions that she holds within Mayo Clinic is the Assistant Chair of Patient Experience within the Division of Gastroenterology and Hepatology, and Physician Chair of the Mayo Quality Academy Fellow Subcommittee; the pinnacle of Dr. Kane’s leadership journey was being President of the American College of Gastroenterology in 2018-2019. She also just completed a 5-year service on the Gastroenterology Specialty Council of the American Board of Internal Medicine.

Prof. Ora Shovman, MD

Senior rheumatologist in the Zabludowicz Center for Autoimmune Diseases

Certified rheumatologist, clinician, and researcher in the field of autoimmune rheumatic diseases.

Prof. Shovman works as a senior rheumatologist in the Zabludowicz Center for Autoimmune Diseases, the Rheumatology unit, and the Institute for Medical Screening of the Sheba Medical Center.

Prof. Shovman is an associate clinical professor at the Tel-Aviv University. She has published many papers in the field of clinical rheumatology and novel laboratory approaches for the diagnosis of autoimmune rheumatic diseases.

Jonathan Shapiro, MD

Dermatologist, manager of Tele-Dermatology service in Maccabi healthcare services

Certified dermatologist, clinician and researcher specializing in psoriasis comorbidities and data mining techniques.

Dr. Shapiro is the manager of the Tele-dermatology service in Maccabi healthcare services.

He started as a computer programmer and database analyst before completing his residency in dermatology and his career was based on combining his knowledge and experience in both fields.

Amir Ben Tov, MD

Senior Clinical Researcher, “KSM”

Certified pediatric gastroenterologist, clinician, and researcher specializing in Celiac Disease at KSM (Kahn-Sagol-Maccabi), the research and innovation center of Maccabi Healthcare Services.

 

KSM leads advanced global health improvements collaborating with well-known scientists, researchers, academic institutions, pharmaceutical companies, startups, and tech companies to create and expedite medical breakthroughs, as well as co-operations within the global health ecosystem allowing groundbreaking discoveries and solutions—shaping the future of health.

www.ksminnovation.com

Strategic Advisory Board

Jack Friedman

Former Chief Executive Officer, Providence Health Plan

Retired Senior Vice President, Accountable Care Services and Payer Relations, Providence Health & Services, and Chief Executive Officer, Providence Health Plan

Current: Professor, George Washington University, Milken Institute of Public Health.

Jack Friedman was senior vice president of accountable care services and payer relations for Providence Health & Services and chief executive officer of Providence Health Plan until July 2015. In his role, Jack was responsible for the strategic direction of accountable care delivery and financing models to improve quality, cost and access throughout Providence Health & Services’ five-state region. Jack also drove strategy and operations of Providence Health Plan, serving 400,000 people.

J. Nwando Olayiwola, MD, MPH, FAAFP

Chief Health Equity Officer & Senior Vice President, Humana, Inc.

Dr. J. Nwando Olayiwola is the inaugural Chief Health Equity Officer and Senior Vice President of Humana, Inc. In this role, she is responsible for setting a health equity agenda and strategy to promote health equity across all Humana lines of business. She has been a national leader in technology-enabled and artificial intelligence empowered primary care and has led widespread implementation of various technologies. She currently also serves as a Board-certified practicing family physician at the Heart of Ohio Community Health Center in Columbus, OH. Dr. Olayiwola is an Adjunct Professor at The Ohio State University College of Public Health & College of Medicine. She was elected into the prestigious National Academy of Medicine in 2021 and has also been named the Woman of the Year by the American Telemedicine Association and Public Health Innovator of the Year by the Harvard School of Public Health.

 

Want to connect the dots of undiagnosed autoimmune diseases with us?

×